MaRS Centre
South Tower Suite 200 101 College Street
Toronto, ON M5G 1L7
Canada
416-673-8487
https://www.telodx.com
Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter:
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Dr. Sabine Mai Ph.D. | Founder, Interim CEO, Chair of the Clinical & Scientific Advisory Board and Director | 30k | N/A | N/A |
Dr. Sherif Louis MSc, Ph.D., PMP | President & CTO | 231,51k | N/A | N/A |
Mr. Christopher Ross CPA, CGA | Chief Financial Officer | 67,5k | N/A | N/A |
Telo Genomics Corp., a biotech company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific Telo Genomics Corp., a molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions. It provides TeloView-SMM application; TeloView, an analysis software platform for prediction of genomic instability. It has a collaboration agreement with the Mayo Clinic to validate its SMM tests for multiple myeloma. Telo Genomics Corp. is headquartered in Toronto, Canada.
Telo Genomics Corp.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.